Why a Rapid Mass Spectrometry Method Can Work for Some Drugs but Struggle With THC
The words “mass spectrometry” do not guarantee that a rapid method measures every drug accurately. A wooden-tip electrospray study reported promising results for several drugs, while THC and THC-COOH presented important quantitative limitations.
A faster route into the instrument
The investigators evaluated wooden-tip electrospray ionization mass spectrometry for drugs in urine and oral fluid. The approach introduces material from a small wooden tip without a conventional chromatographic separation, reducing preparation and analysis time.
Much of the validation relied on biological matrices fortified with known standards. This establishes what happened to known chemicals under laboratory conditions; it is not a cohort study connecting drug results with symptoms or driving behavior.
The cannabinoid exceptions matter
Several tested drugs produced satisfactory analytical results. THC and its carboxy metabolite, however, did not demonstrate equally satisfactory quantitative accuracy and precision. Their detection performance also did not meet all relevant screening cutoffs evaluated by the authors.
A summary listing all tested drugs alongside the method’s best performance would conceal this distinction. Performance must be reported separately for each analyte and matrix. Success with methamphetamine cannot validate a THC-COOH urine measurement.
Detection, quantitation, and confirmation
Detecting a signal is different from assigning an accurate concentration. Quantitation requires acceptable bias and variability across the relevant range, including near a decision threshold. A fast result can be useful for triage while still needing a more thoroughly validated analytical procedure.
The absence of chromatography changes the method’s handling of complex biological material. Its practical benefits should therefore be considered alongside matrix effects, interference testing, and the cannabinoid-specific limitations reported in this paper.
How to evaluate a laboratory claim
Ask for validation data for the exact cannabinoid, specimen, concentration range, and instrument configuration used in the case. Determine whether the reported number is a screening estimate or a validated quantitative result, and whether reference measurements support it.
Even an analytically sound urine or oral-fluid result does not independently establish impairment. This paper concerns measurement performance. It contains no behavioral endpoint that would convert its cannabinoid signals into a finding about a person’s ability to drive.
For related context, see our discussion of why urine and blood drug results are not interchangeable.
Primary research
Tsz-Tsun Ng; Pui-Kin So; Bin Hu; Zhong-Ping Yao. Rapid detection and quantitation of drugs-of-abuse by wooden-tip electrospray ionization mass spectrometry. Journal of Food and Drug Analysis (2019). DOI: 10.1016/j.jfda.2018.09.002.
